• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变异类型影响嗜铬细胞瘤-副神经节瘤的表型和恶性程度。

variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma.

机构信息

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

Department of Medicine II, University of Freiburg Faculty of Medicine, Freiburg, Germany.

出版信息

J Med Genet. 2023 Jan;60(1):25-32. doi: 10.1136/jmedgenet-2020-107656. Epub 2021 Nov 8.

DOI:10.1136/jmedgenet-2020-107656
PMID:34750193
Abstract

BACKGROUND

Traditional genotype-phenotype correlations for the succinate dehydrogenase-complex II (SDH) genes link variants to thoracic-abdominal pheochromocytoma-paraganglioma (PPGL) and variants to head and neck paraganglioma (HNPGL). However, in a recent study we found strong and specific genotype-phenotype associations for variants. In the present study we zoom in on the genotype-phenotype associations of gene variants, considering the impact of individual gene variants on disease risk and risk of malignancy.

METHODS

We analysed two large independent data sets, including a total of 448 patients with PPGL and HNPGL, and studied the association of missense or truncating variants with tumour incidence, age of onset and malignancy risk using binomial testing and Kaplan-Meier analysis.

RESULTS

Compared with missense variants, truncating variants were significantly and consistently more common in patients with PPGL, by a 20 percentage point margin. Malignancy was also significantly more common in truncating versus missense variant carriers. No overall differences in age of PPGL onset were noted between carriers of the two variant types, although some individual variants may differ in certain cases. Missense variants were marginally over-represented among patients with HNPGL, but the difference was not statistically significant.

CONCLUSION

truncating variants convey an elevated risk for development of both PPGL and malignancy compared with missense variants. These results further support earlier robust associations between truncating variants and PPGL, and also suggest that the two variant types differ in their impact on complex II function, with PPGL/HNPGL tissues displaying differing sensitivities to changes in complex II function.

摘要

背景

琥珀酸脱氢酶复合物 II(SDH)基因的传统基因型-表型相关性将变体与胸腹部嗜铬细胞瘤-副神经节瘤(PPGL)联系起来,而变体与头颈部副神经节瘤(HNPGL)联系起来。然而,在最近的一项研究中,我们发现了变体的强烈和特异性基因型-表型关联。在本研究中,我们关注基因变体的基因型-表型关联,考虑个体基因变体对疾病风险和恶性肿瘤风险的影响。

方法

我们分析了两个独立的大型数据集,包括总共 448 名患有 PPGL 和 HNPGL 的患者,并使用二项式检验和 Kaplan-Meier 分析研究了错义或截断变体与肿瘤发生率、发病年龄和恶性肿瘤风险的关联。

结果

与错义变体相比,截断变体在 PPGL 患者中明显且一致更为常见,相差 20 个百分点。与错义变体携带者相比,恶性肿瘤在截断变体携带者中也更为常见。两种变体类型的 PPGL 发病年龄之间没有总体差异,但在某些情况下,某些个别变体可能存在差异。错义变体在 HNPGL 患者中略为过度表达,但差异无统计学意义。

结论

与错义变体相比,截断变体传达了发生 PPGL 和恶性肿瘤的风险增加。这些结果进一步支持了截断变体与 PPGL 之间的早期强关联,并且还表明两种变体类型在其对复合物 II 功能的影响方面存在差异,PPGL/HNPGL 组织对复合物 II 功能变化的敏感性不同。

相似文献

1
variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma.变异类型影响嗜铬细胞瘤-副神经节瘤的表型和恶性程度。
J Med Genet. 2023 Jan;60(1):25-32. doi: 10.1136/jmedgenet-2020-107656. Epub 2021 Nov 8.
2
Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.变异类型与 SDHB、SDHC 和 SDHD 相关的嗜铬细胞瘤-副神经节瘤的疾病特征有关。
J Med Genet. 2020 Feb;57(2):96-103. doi: 10.1136/jmedgenet-2019-106214. Epub 2019 Sep 6.
3
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes , and .琥珀酸脱氢酶亚基基因 和 种系变异与肿瘤风险及基因型-表型相关性
J Med Genet. 2018 Jun;55(6):384-394. doi: 10.1136/jmedgenet-2017-105127. Epub 2018 Jan 31.
4
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.358 例种系 SDHB 和 SDHD 基因突变患者的肿瘤风险和基因型-表型-生物型分析。
Hum Mutat. 2010 Jan;31(1):41-51. doi: 10.1002/humu.21136.
5
Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma.评估非综合征性嗜铬细胞瘤、副神经节瘤和头颈部副神经节瘤个体中 SDHB、SDHD 和 VHL 基因易感性检测的价值。
Clin Endocrinol (Oxf). 2013 Jun;78(6):898-906. doi: 10.1111/cen.12074. Epub 2013 Apr 6.
6
Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.韩国散发性嗜铬细胞瘤/副神经节瘤患者的胚系突变及基因型-表型相关性
Clin Genet. 2014 Nov;86(5):482-6. doi: 10.1111/cge.12304. Epub 2013 Nov 15.
7
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.副神经节瘤和嗜铬细胞瘤易感性中线粒体复合物II亚基SDHD、SDHB和SDHC的遗传分析。
Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33. doi: 10.1046/j.1365-2265.2003.01914.x.
8
Risk of metastatic pheochromocytoma and paraganglioma in mutation carriers: a systematic review and updated meta-analysis.携带 突变的患者发生转移性嗜铬细胞瘤和副神经节瘤的风险:系统评价和更新的荟萃分析。
J Med Genet. 2020 Apr;57(4):217-225. doi: 10.1136/jmedgenet-2019-106324. Epub 2019 Oct 24.
9
International initiative for a curated variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.国际 curated 变异数据库倡议,以改善遗传性副神经节瘤和嗜铬细胞瘤的诊断。
J Med Genet. 2022 Aug;59(8):785-792. doi: 10.1136/jmedgenet-2020-107652. Epub 2021 Aug 27.
10
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.嗜铬细胞瘤/副神经节瘤综合征的临床表现及外显率
J Clin Endocrinol Metab. 2006 Mar;91(3):827-36. doi: 10.1210/jc.2005-1862. Epub 2005 Nov 29.

引用本文的文献

1
Genetic Testing Referral Rates for Pheochromocytoma and Paraganglioma in an Academic Tertiary Centre.学术三级中心嗜铬细胞瘤和副神经节瘤的基因检测转诊率
Clin Endocrinol (Oxf). 2025 Aug;103(2):147-156. doi: 10.1111/cen.15248. Epub 2025 Apr 15.
2
Clinicopathological and genomic analysis of pediatric pheochromocytoma and sympathetic paraganglioma.儿童嗜铬细胞瘤和交感神经节细胞瘤的临床病理及基因组分析
Endocr J. 2025 Apr 1;72(4):399-412. doi: 10.1507/endocrj.EJ24-0584. Epub 2025 Feb 1.
3
Durable and deep response to CVD chemotherapy in SDHB-mutated metastatic paraganglioma: case report.
SDHB突变型转移性副神经节瘤对CVD化疗的持久且深度反应:病例报告
Front Endocrinol (Lausanne). 2024 Dec 18;15:1483516. doi: 10.3389/fendo.2024.1483516. eCollection 2024.
4
SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior?SDHB 相关嗜铬细胞瘤:它们的临床行为如何?
Ann Surg Oncol. 2024 Dec;31(13):9007-9013. doi: 10.1245/s10434-024-16120-z. Epub 2024 Oct 9.
5
Algorithm of genetic diagnosis for patients with head and neck paraganglioma-update.头颈部副神经节瘤患者的基因诊断算法——更新版
Front Neurol. 2024 Aug 29;15:1437027. doi: 10.3389/fneur.2024.1437027. eCollection 2024.
6
Proteomic characterization of head and neck paraganglioma and its molecular classification.头颈部副神经节瘤的蛋白质组学特征及其分子分类
Front Mol Neurosci. 2024 Aug 21;17:1391568. doi: 10.3389/fnmol.2024.1391568. eCollection 2024.
7
Outcomes of SDHB Pathogenic Variant Carriers.SDHB 致病性变异携带者的结局。
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2400-2410. doi: 10.1210/clinem/dgae233.
8
Preferential hypermethylation in SDH-deficient wild-type GIST.SDH 缺陷型野生型 GIST 的优先超甲基化。
J Clin Pathol. 2023 Dec 14;77(1):34-39. doi: 10.1136/jcp-2022-208462.
9
Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes.假说:为何不同类型的 SDH 基因突变导致不同的肿瘤表型。
Genes (Basel). 2022 Jun 7;13(6):1025. doi: 10.3390/genes13061025.